Exploring Nitric Oxide (NO)-Releasing Celecoxib Derivatives as Modulators of Radioresponse in Pheochromocytoma Cells

COX-2 can be considered as a clinically relevant molecular target for adjuvant, in particular radiosensitizing treatments. In this regard, using selective COX-2 inhibitors, e.g., in combination with radiotherapy or endoradiotherapy, represents an interesting treatment option. Based on our own findin...

Full description

Bibliographic Details

Published in:	Molecules
Main Authors:	Florian Brandt, Martin Ullrich, Verena Seifert, Cathleen Haase-Kohn, Susan Richter, Torsten Kniess, Jens Pietzsch, Markus Laube
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Subjects:	cancer endoradionuclide therapy NO donors pheochromocytoma (pseudo)hypoxia radiation therapy
Online Access:	https://www.mdpi.com/1420-3049/27/19/6587